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differences in outcomes for aortic aneurysm repair3 and
lower extremity revascularization,4 but the difference in
outcomes for the treatment of carotid arterial disease
remains controversial. Post hoc analysis results of the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET)5,6 and the Asymptomatic Carotid
Atherosclerosis Study (ACAS)7 suggest that carotid
endarterectomy (CEA) may not be as efficacious in
women as it is in men. The ACAS analysis results sug-
gested that the merit of prophylactic CEA in women who
were asymptomatic was compromised by a higher periop-
erative stroke and mortality rate. According to the
NASCET results, CEA may not be as beneficial for
women who are symptomatic with a 50% to 69% internal
carotid stenosis because of a lower risk of stroke in women
as compared with men who were randomized to undergo
medical management. Several investigators have chal-
lenged these conclusions, however. Akbari et al8 found no
That there are gender differences in the prevalence
and severity of peripheral arterial disease is well known.
This difference is supported by the increased prevalence of
aneurysms1 and arterial occlusive disease2 in men as com-
pared with women. Evidence also exists that suggests that
the gender difference in the prevalence of disease is
accompanied by differences in the outcome of therapy in
men and women. Earlier studies have addressed gender
From the Department of Vascular Surgery, The Cleveland Clinic Foundation.
Competition of interest: nil.
Presented at the Fifteenth Annual Meeting of the Eastern Vascular Society,
Washington, DC, May 4-6, 2001.
Reprint requests: Timur P. Sarac, MD, Department of Vascular Surgery,
The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH
44195.
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00 + 0 24/6/120375
doi:10.1067/mva.2002.120375
Gender as a primary predictor of outcome after
carotid endarterectomy
Timur P. Sarac, MD, Norman R. Hertzer, MD, Edward J. Mascha, MS, Patrick J. O’Hara, MD,
Leonard P. Krajewski, MD, Daniel G. Clair, MD, Matthew T. Karafa, MS, and Kenneth Ouriel, MD,
Cleveland, Ohio
Objective: Post hoc analysis results of the North American Symptomatic Carotid Endarterectomy Trial and the
Asymptomatic Carotid Atherosclerosis Study suggest that carotid endarterectomy (CEA) may not be as efficacious in
women as it is in men. This study was undertaken for the evaluation of whether there is a difference between men and
women in early postoperative outcome after CEA and whether such a difference is consistent across other predictors.
Methods: We conducted a retrospective review of all CEAs entered into our departmental registry between January 1,
1989, and November 30, 2000. A total of 3422 CEAs was performed in 3077 consecutive patients. The ratio of men
to women was 2:1, and the ratio of patients who were asymptomatic to patients who were symptomatic was 2.3:1. The
following in-hospital outcome data were analyzed: transient ischemic attack (TIA), stroke, mortality, combined TIA or
stroke, and combined stroke or mortality. Univariate and multivariate analysis results of selected risk factors for an
adverse perioperative event were assessed with generalized estimating equation analysis with backwards selection. The
following risk factors were considered: gender, preoperative neurologic status, urgency of operation, type of arteri-
otomy repair, reoperative CEA for recurrent stenosis, history of cardiopulmonary disease, previous coronary artery
intervention, simultaneous CEA and coronary bypass grafting surgery, renal failure, and diabetes.
Results: Univariate analysis results of gender differences revealed that women were at higher risk for a postoperative
TIA or stroke (3.3% for women versus 2.1% for men; odds ratio [OR], 1.6; confidence interval [CI], 1.04 to 2.5; P =
.03) and for postoperative stroke or mortality (3.1% for women versus 2.1% for men; OR, 1.6; CI, 1.04 to 2.5; P =
.03). Multivariate analysis results showed that female gender was an independent predictor for a postoperative TIA or
stroke (OR, 1.7; CI, 1.1 to 2.6; P = .03). Further analysis disclosed that women who were asymptomatic were at greater
risk than were men for postoperative stroke or mortality (OR, 2.3; CI, 1.3 to 3.9; P = .003). Conversely, there was no
gender association for postoperative stroke or mortality in the consideration of only patients who were symptomatic
(OR, 1.0; CI, 0.45 to 2.1; P = .95). The interaction between women and preoperative symptoms approached signifi-
cance (P = .07) with respect to postoperative stroke and mortality rate, which suggests that the gender effect could be
influenced by the clinical presentation.
Conclusion: The combined TIA or stroke and stroke or mortality rates are higher in women as compared with men in
the postoperative period, but these risks remain acceptable when CEA is performed for appropriate indications. The
interaction between symptoms and gender suggests that, in patients who are asymptomatic, women are more likely than
are men to have early complications. However, there is no gender difference in patients who are symptomatic.
Therefore, despite a low postoperative complication rate, CEA is appropriate in both women who are asymptomatic
and women who are symptomatic only if the postoperative TIA, stroke, and mortality rates are appreciably lower than
in the natural history of medical management of these patients. (J Vasc Surg 2002;35:748-53.)
gender differences in long-term stroke and mortality rates
after CEA. More recently, Rockman et al9 reported their
comparison of CEA in men and women and found no dif-
ference in the perioperative stroke rate.
Women have had slightly higher early stroke and mor-
tality rates than have men in our experience, a finding that
has been clinically subtle but statistically significant.10,11
This study was undertaken for the further investigation of
whether these differences are consistent across other base-
line variables.
METHODS
From January 1, 1989, to November 30, 2000, all the
patients who underwent CEA performed by members of
our department were prospectively entered into a comput-
erized database. As indicated in Table I, there was a total of
3422 CEAs in 3077 patients (2274 men and 1148
women). One CEA was performed in 2744 patients (89%),
two CEAs were performed in 321 patients (10%), and
three CEAs were performed in 12 patients (0.4%). For 160
of the patients who underwent a single operation (5.8%),
that single operation was a reoperative CEA for recurrent
carotid stenosis. Of those patients who underwent two
operations, 30 (11%) had one reoperation and three (0.9%)
had bilateral reoperations. For those patients who under-
went three operations, nine (75%) had one reoperation,
two (16%) had two reoperations, and one (8.3%) had all
three as reoperations. The median interval between bilat-
eral operations was 75 days (range, 0 to 10 years).
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Surgical indications and techniques. The preopera-
tive imaging studies consisted of duplex ultrasound scan-
ning, intraarterial arteriography, or both. The ultrasound
scan criteria for 80% to 99% internal carotid stenosis was
adapted from the University of Washington recommenda-
tions and required both a peak systolic velocity of more than
240 cm/s and an end-diastolic velocity of more than 135
cm/s.12 Preoperative arteriographic results were obtained
for the vast majority of patients before 1995, but since that
time, arteriography has been used to supplement the duplex
scan results only on a selective basis. Our surgical indications
for CEA have previously been described.13,14 In general, the
patients who were symptomatic underwent CEA if the index
lesion represented ≥70% stenosis of the internal carotid
artery (ICA), unless a lesion of less severity (50% to 69%)
correlated clinically with persistent transient ischemic attacks
(TIAs) despite antiplatelet therapy. For most patients who
were asymptomatic, CEA was performed if there were at
least 80% stenosis of the ICA or 60% to 79% stenosis of the
ipsilateral ICA in the presence of an ICA occlusion on the
contralateral side. Nearly all the CEAs were performed with
general anesthesia with routine intraluminal shunting.
Furthermore, 3193 of the 3422 operations (93%) in this
series were performed in conjunction with patch angioplasty
with either the greater saphenous vein from the upper thigh
(n = 2499; 73%) or polyester material (n = 694; 20%).
Outcome assessment and statistical methods. The
primary outcome measures for analysis were in-hospital TIA,
stroke, mortality, any neurologic event (TIA or stroke), and
Table I. Demographic data
Men Women Total
Overall number 2274 (66.5%) 1148 (33.5%) 3422
Mean age (years) 68.86 (range, 35-93) 69.24 (range, 37-91) 68.9
Table II. Baseline variables in men and women who underwent carotid endarterectomy
Total no. of patients Men (n = 2274) Women (n = 1148) P value*
Redo CEA 220 139 (6.1%) 81 (7.1%) .53
Urgency 55 32 (1.4%) 23 (2.0%) .3
History of stroke 374 258 (11.4%) 116 (10.1%) .19
History of TIA 552 351 (15.4%) 201 (17.5%) .24
Symptomatic (history of stroke/TIA) 893 591 (26.0%) 302 (26.3%) .88
Primary repair 229 152 (6.7%) 77 (6.7%) .81
Vein patch 2499 1651 (72.6%) 848 (73.9%) .22
Dacron graft patch 694 471 (20.7%) 223 (19.4%) .17
Coronary artery disease 2303 1652 (72.7%) 651 (56.7%) <.001
Previous CABG 1437 1092 (48.0%) 345 (30.1%) <.001
Previous PTCA 190 138 (6.1%) 52 (4.5%) .15
Combined CEA/CABG 422 296 (13.0%) 126 (11.0%) .1
Pulmonary disease 359 257 (11.3%) 102 (8.9%) .06
Renal disease (creatinine level, >2.0) 168 123 (5.4%) 45 (3.9%) .07
Diabetes mellitus 775 506 (22.3%) 269 (23.4%) .77
Insulin-dependent diabetes 278 168 (7.4%) 110 (9.6%) .07
CEA, Carotid endarterectomy; TIA, transient ischemic attack; CABG, coronary artery bypass graft; PTCA, percutaneous transluminal coronary angioplasty.
*P value determined with univariate generalized estimating equation analysis adjusted for repeated operations.
combined stroke or mortality. The following risk factors for
an adverse perioperative event were assessed with univariate
analysis with the generalized estimating equation:15 gender,
the preoperative neurologic status (stroke, TIA, stroke plus
TIA, asymptomatic), the urgency of operation, the type of
arteriotomy repair (primary closure, vein or polyester patch),
reoperative CEA for recurrent stenosis, coronary artery dis-
ease, previous coronary artery bypass grafting (CABG) or
percutaneous transluminal coronary angioplasty, simultane-
ous CEA/CABG, chronic obstructive pulmonary disease,
renal failure, diabetes, and insulin-dependent diabetes. P val-
ues of less than .05 were considered to be significant.
The risk factors for multivariate analysis were assessed
with the generalized estimating equation analysis, which is
analogous to logistic regression analysis but adjusts for the
repeated nature of the data derived from patients who
underwent multiple operations. All the risk factors that
met a univariate significance criterion of a P value less than
.15 were considered for the multivariate model. In addi-
tion, we examined all two-way interactions for these risk
factors for both outcomes. Backwards selection was used
to restrict this model to include the main effects of P value
.05 or less (unless involved in an interaction) and the
interaction effects of P value .15 or less.
RESULTS
The average number of CEAs performed each year was
294 ± 53 (standard deviation), and the ratio of CEAs per-
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formed in men as compared with women (2:1) remained
relatively constant throughout the study period (Table I).
Of the 3422 CEAs in this series, 220 (6.4%) were reoper-
ative procedures for recurrent stenosis and 422 (12%) were
performed simultaneously with CABG. The baseline vari-
ables for men and women are summarized in Table II. A
significantly higher number of men had coronary artery
disease and had undergone CABG or percutaneous trans-
luminal coronary angioplasty. In addition, there were
trends that suggested a greater prevalence of chronic
obstructive pulmonary disease and renal insufficiency in
men and of insulin-dependent diabetes in women.
The in-hospital outcome data are provided in Table
III. There was a significantly higher incidence rate of any
postoperative neurologic event (TIA or stroke) in women.
The combined stroke and mortality rate also was signifi-
cantly higher in women, although gender differences did
not attain statistical significance with respect to stroke risk
alone. The outcome measures are correlated according to
the preoperative neurologic status in Table IV. The P
value for the interaction between gender and symptoms is
nearly significant at our P value less than .15 criterion for
only the combined stroke or mortality rate, which indi-
cates that the gender effect for this outcome depends to
some extent on whether prior symptoms had occurred.
Women who underwent CEA for asymptomatic carotid
stenosis were more likely than men to have a postoperative
stroke, stroke or death, or any neurologic event (TIA or
Table III. Outcome of procedure by gender at time of discharge from index hospitalization
Total events Men (n = 2274) Women (n = 1148) OR (95% CI)* P value†
TIA 20 11 (0.48%) 9 (0.78%) 1.63 (0.67-3.9) .28
Stroke 65 36 (1.6%) 29 (2.5%) 1.61 (0.97-2.7) .07
Mortality 34 20 (0.88%) 14 (1.2%) 1.39 (0.7-2.8) .35
TIA or stroke 85 47 (2.1%) 38 (3.3%) 1.62 (1.04-2.5) .03
Stroke or mortality 85 47 (2.1%) 38 (3.1%) 1.63 (1.04-2.5) .03
*Odds of outcome in female patients versus male patients.
†P value determined with univariate generalized estimating equation adjusted for multiple reoperations.
OR, Odds ratio; CI, confidence interval; TIA, transient ischemic attack.
Table IV. Univariate analysis results of in-hospital outcome by gender
Interaction P value* Men (n = 2274) Women (n = 1148) P value†
TIA .84 Symptomatic 2/688 (0.29%) 2/361 (.55%) .51
Asymptomatic 9/1586 (0.57%) 7/787 (.89%) .38
Stroke .23 Symptomatic 20/688 (2.9%) 12/361 (3.3%) .8
Asymptomatic 16/1586 (1.01%) 17/787 (2.2%) .03
Mortality .78 Symptomatic 8/688 (1.2%) 7/361 (1.9%) .72
Asymptomatic 12/1586 (0.76%) 7/787 (.89%) .36
TIA or stroke .37 Symptomatic 22/688 (3.2%) 14/361 (3.9%) .57
Asymptomatic 25/1586 (1.6%) 24/787 (3.1%) .02
Stroke or mortality .16 Symptomatic 23/688 (3.3%) 14/361 (3.9%) .87
Asymptomatic 24/1586 (1.5%) 24/787 (3.1%) .01
Symptomatic, n = 893; asymptomatic, n = 2529.
*P value determined with generalized estimating equation model including female, symptomatic, and female-by-symptomatic interaction.
†P value determined with generalized estimating equation model for gender effect within symptomatic/asymptomatic.
TIA, Transient ischemic attack.
stroke). Conversely, there was no gender difference in any
outcome for patients who underwent CEA for sympto-
matic carotid disease.
Each categoric factor in Table II was analyzed for its
possible influence on adverse postoperative events. The
results of this analysis are provided in Table V for com-
bined TIA or stroke rate and in Table VI for combined
stroke or mortality rate. The following factors were found
to be associated with a significant risk rate for postopera-
tive TIA or stroke with univariate analysis: women (3.3%)
versus men (2.1%); history of preoperative TIA (3.8% ver-
sus 2.2%); either preoperative TIA or stroke (3.5% versus
2.1%); and simultaneous CEA/CABG procedures (5.0%
versus 2.1%). The following factors were found to be asso-
ciated with a significant risk for postoperative stroke or
mortality rate: women (3.3%) versus men (2.1%); preoper-
ative TIA (3.8% versus 2.2%); either preoperative TIA or
stroke (3.5% versus 2.1%); carotid reoperations (4.6% ver-
sus 2.3%); previous CABG (3.1% versus 2.1%); and simul-
taneous CEA/CABG procedures (7.6% versus 1.8%).
Multivariate analyses were performed for the further clar-
ification of the independence of categoric factors as predic-
tors of adverse events. Factors found with univariate analysis
results to be associated with a particular outcome measure
(TIA/stroke and stroke/death) with a probability of P value
less than .15 were entered into a multivariate model. No two-
way interactions met our significance criterion for the TIA or
stroke rate model. For the stroke or mortality rate model,
only the interaction between women and symptoms (P =
.07) met our significance criterion for remaining in the
model. The significant predictors of postoperative TIA or
stroke as determined with backwards regression analyses were
female gender, primary arteriotomy repair, preoperative
symptoms, and simultaneous CEA/CABG (Table VII). The
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significant predictors of postoperative stroke or mortality
were female gender, primary arteriotomy repair, preoperative
symptoms, simultaneous CEA/CABG, and the interaction
between women and the preoperative neurologic status
(Table VIII). Intragender comparison results of operative
indications revealed that the combined stroke and mortality
rate was significantly higher in men who were symptomatic
than in men who were asymptomatic (OR, 2.6; CI, 1.4 to
4.7; P = .002). However, there was no such difference
between women who were symptomatic and women who
were asymptomatic (OR, 1.1; CI, 0.54 to 2.2). This gender-
by-prior-symptom interaction indicates that the gender effect
depends on whether prior symptoms had occurred. The risk
rate of stroke or mortality in patients who were symptomatic
is similar for men and women (OR, 0.98; CI, 0.45 to 2.1),
but in patients who were asymptomatic, the combined stroke
and mortality rate was twice as high in women (OR, 2.3; CI
1.3 to 3.9; P = .003).
DISCUSSION
The number of patients with extracranial carotid arte-
rial disease undoubtedly will increase dramatically with the
Table V. Univariate analysis results of postoperative transient ischemic attack or stroke
Risk factor No risk factor OR (95% CI) P value*
Women 38/1148 (3.3%) 47/2274 (2.1%) 1.6 (1.04-2.5) .03
History of TIA 21/552 (3.8%) 64/2870 (2.2%) 1.7 (1.04-2.8) .04
Symptomatic 31/890 (3.5%) 54/2529 (2.1%) 1.6 (1.03-2.5) .04
Combined CEA/CABG 21/422 (5.0%) 64/3000 (2.1%) 2.4 (1.5-4.0) <.001
*P value determined with univariate generalized estimating equation model.
OR, Odds ratio; CI, confidence interval; TIA, transient ischemic attack; CEA, carotid endarterectomy; CABG, coronary artery bypass graft.
Table VI. Univariate analysis results of postoperative stroke or mortality
Risk factor No risk factor OR (95% CI) P value*
Women 38/1148 (3.3%) 47/2274 (2.1%) 1.6 (1.04-2.5) .03
History of TIA 21/552 (3.8%) 64/2870 (2.2%) 1.7 (1.03-2.8) .04
Symptomatic 31/893 (3.5%) 54/2529 (2.1%) 1.6 (1.02-2.5) .04
Redo CEA 10/220 (4.6%) 75/3202 (2.3%) 1.9 (0.99-3.8) .05
Previous CABG 44/1437 (3.1%) 41/1985 (2.1%) 1.5 (0.99-2.4) .05
Combined CEA/CABG 32/422 (7.6%) 53/3000 (1.8%) 4.6 (2.9-7.1) <.001
*P value determined with univariate generalized estimating equation model.
OR, Odds ratio; CI, confidence interval; TIA, transient ischemic attack; CEA, carotid endarterectomy; CABG, coronary artery bypass graft.
Table VII. Multivariate analysis results of factors associ-
ated with postoperative transient ischemic attack or stroke
OR (95% CI) P value
Women 1.65 (1.06-2.57) .03
Primary repair 2.38 (1.00-5.66) .05
Symptoms 1.70 (1.09-2.67) .02
CEA/CABG 2.63 (1.59-4.35) .001
OR, Odds ratio; CI, confidence interval; CEA/CABG, combined carotid
endarterectomy and coronary artery bypass graft.
aging of the population. The relative number of women
with carotid disease probably will rise disproportionately,
augmented by the 5.7-year differential in life expectancy
of women as compared with men.16 However, the per-
ceived increased incidence rate of cerebrovascular disease
in men as compared with women has translated into a
lower number of CEAs performed in women than would
be expected on the basis of gender-adjusted disease preva-
lence alone.17 As further impetus for a conservative
approach for women with carotid disease, the ACAS doc-
umented a lower long-term stroke rate in women than in
men who underwent medical treatment and a higher peri-
operative complication rate in women than in men who
were randomized to CEA.7 Furthermore, the NASCET
documented a lower stroke rate in women than in men
who had symptomatic 50% to 69% carotid stenosis and
were randomized to optimal medical management alone.6
The outcome measures used in this study were derived
from established reporting guidelines that recommended
the analysis of combined results (TIA/stroke and
stroke/mortality) and of isolated complications.18 Our in-
hospital outcomes were similar to the 30-day results of the
ACAS with respect to an almost two-fold increase in the
risk rate of postoperative TIA, stroke, or mortality in
women who were asymptomatic and underwent CEA.
Similar to the NASCET results in patients with moderate
carotid stenosis, we were unable to document gender dif-
ferences in the outcome of CEA performed in patients
who were symptomatic. However, we are not able to
report on a similar cohort of patients who underwent
medical treatment. Multivariate analysis was used in the
assessment of whether gender itself was an independent
predictor of outcome apart from the preoperative neuro-
logic status. These analysis results confirmed a higher peri-
operative event rate in women who were asymptomatic,
the group for which the risk/benefit ratio of prophylactic
CEA generally is conceded to be most controversial.
Nevertheless, the combined rates for TIA/stroke and
stroke/mortality for both men and women in our series
are slightly better than those rates in the NASCET, are
comparable with those rates in the ACAS, and fall well
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within the guidelines recommended by the American
Heart Association.19
Admittedly, there are limitations to this study. It is ret-
rospective, there is no independent neurologic verification
of outcome, and outcomes are measured in hospital and
not at 30 days. Our registry database does not contain
some of the information that would be necessary for the
investigation of several factors that could be responsible
for the gender-specific outcomes of CEA in women who
are asymptomatic, such as the diameter of the ICA, the
precise degree of stenosis, the severity of contralateral
carotid disease, and an array of hematologic parameters
that conceivably might influence the early and late results
of surgical treatment, and we do not report left-sided dis-
ease as a variable. Our traditional policy of use of CEA for
only patients who are asymptomatic in the presence of
80% to 99% stenosis with duplex ultrasound scanning
makes it unlikely that our indications for CEA were any
different in women than in men. Carotid reoperations
were evenly distributed between both genders and were
not found to be a predictor of outcome in either patients
who were symptomatic or patients who were asympto-
matic. We did not measure vessel size, but if diameter of
the ICA were truly an important consideration, outcome
differences probably should have been identified in
patients who were symptomatic and in patients who were
asymptomatic. Furthermore, patch angioplasty was rou-
tinely performed for almost all of the patients in this series,
and although we did find that primary arteriotomy repair
was a predictor of TIA/stroke and stroke/mortality rates,
it was not gender specific. There have been reports that
hormones, specifically estrogen, influence the develop-
ment of atherosclerosis,20 but it is unlikely that this factor
would influence the early outcome of CEA in the absence
of other manifestations of hypercoagulability.
Despite an increased interest in gender-specific out-
come data for CEA after the NASCET and the ACAS dis-
closures,8,9,21-23 only a few subsequent studies have
addressed this issue specifically for the investigation of
whether gender might merely represent a proxy for other
confounding variables, such as the preoperative neurologic
Table VIII. Multivariate analysis results of factors associated with postoperative stroke or death
Effect OR (95% CI) P value*
CEA/CABG 5.17 (3.29-8.10) <.001
Primary repair 2.55 (1.02-6.36) .04
Female-by-symptoms interaction NA .07
Women versus men
Symptomatic 0.98 (0.45-2.1) .95
Asymptomatic 2.29 (1.3-3.9) .003
Asymptomatic versus symptomatic 
Women 1.1 (0.54-2.2) .79
Men 2.58 (1.4-4.7) .002
*P values determined with multivariable generalized estimating equation model.
OR, Odds ratio; CI, confidence interval; CEA/CABG, combined carotid endarterectomy and coronary artery bypass
graft; NA, not applicable because of interaction.
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status. Rockman et al9 recently reported the results of a
large series of CEAs from New York University and found
that there was no difference in postoperative outcome
irrespective of patient gender or the preoperative symp-
toms. Only 34% of the patients in this series had asympto-
matic stenosis as their indication for operation, however,
compared with 70% of the patients in our own series.
Another contemporary study by Akbari et al8 also
reviewed a large series of CEAs, and although the overall
early outcome was equivalent in men and in women, gen-
der differences similar to those in our series were identified
among patients who underwent their operations for
asymptomatic carotid stenosis. A third large study that
used hospital discharge data from the state of Florida
recently determined that women had a higher risk for neu-
rologic complications, but like our experience, the clinical
importance of this finding was tempered by the fact that
the overall complication rate still was relatively low.22 The
University of Toronto Carotid Study Group recently
reported that their results from a large series of 1342
CEAs showed no statistical difference between genders in
postoperative outcome after CEA.23 However, this review
did not differentiate between symptomatic and asympto-
matic results with respect to gender. Gollege et al24 found
that women also had a higher stroke or mortality rate than
did men in a series with only patients who were sympto-
matic, but this series was relatively small (460 patients dur-
ing 15 years) in comparison with the others that have been
mentioned.
This work, supported by the results of the NASCET
and ACAS, suggests that in women who are symptomatic
with significant carotid artery stenosis, if there is a lesser
benefit of CEA in women than in men, it may be attrib-
uted to a different natural history of the disease, because
the incidence rate of postoperative complications (mortal-
ity or stroke) is similar. In women who are asymptomatic
with significant carotid stenosis, caution should be used in
the suggestion of CEA because of a higher incidence rate
of perioperative complications than in men and possibly
because of a lower incidence rate of late neurologic events
in women who undergo medical management alone com-
pared with men.
We thank Becky Roberts, who maintains our depart-
mental registry database, and Edwin G. Beven, MD, who
contributed hundreds of patients to this series before his
retirement in 1999.
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